Market Cap 7.97B
Revenue (ttm) 2.09B
Net Income (ttm) -304.90M
EPS (ttm) N/A
PE Ratio 26.83
Forward PE 27.57
Profit Margin -14.56%
Debt to Equity Ratio 0.57
Volume 429,921
Avg Vol 687,578
Day's Range N/A - N/A
Shares Out 54.33M
Stochastic %K 11%
Beta 1.21
Analysts Strong Sell
Price Target $187.57

Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemog...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 297 7000
Fax: 949 297 7001
Address:
52 Discovery, Irvine, United States
DonCorleone77
DonCorleone77 Aug. 21 at 10:17 AM
$MASI $AAPL From Bloomberg Law: "Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool" https://news.bloomberglaw.com/daily-labor-report/masimo-sues-us-customs-over-apple-restoring-watchs-oxygen-tool
0 · Reply
smartkarma
smartkarma Aug. 21 at 6:06 AM
$MASI | Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market? "Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/masimo-corporation-unveils-next-gen-root-monitor-can-its-innovations-help-grap-a-larger-pie-of-the-market
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 21 at 3:01 AM
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature $MASI $AAPL https://stocktwits.com/news/equity/markets/apple-s-watch-war-heats-up-masimo-takes-customs-to-court-over-blood-oxygen-feature/chsSKuFRdL7
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:13 PM
$MASI shares lost 4.6% following FDA clearance for expanded O3 Regional Oximetry indications — a buying opportunity? 🤔 FDA nod for expanded O3 Regional Oximetry indications could drive growth in high-margin brain monitoring, yet shares are down 11.2% year-to-date, underperforming the industry’s 7.6% decline. Discover what's next for Masimo 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-body-8701&ADID=SYND_STOCKTWITS_TWEET_2_2740478_BODY_8701
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 5:13 PM
$MASI dips on FDA win? 🤔 The company just got clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups — yet shares are trading lower. See the full bull/bear setup here 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-teaser-8700&ADID=SYND_STOCKTWITS_TWEET_2_2740478_TEASER_8700
0 · Reply
11thestate
11thestate Aug. 18 at 8:51 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08182025_1 #MASI
0 · Reply
lipmaz
lipmaz Aug. 17 at 12:05 AM
$MASI or $IRTC you can only choose one?
0 · Reply
theflynews
theflynews Aug. 14 at 3:19 PM
Video: Why Masimo Is Sliding Today - $MASI - https://thefly.com/permalinks/entry.php/MASIid4183702?1755184131C38
0 · Reply
healthcareguru
healthcareguru Aug. 11 at 1:54 PM
Dramatically oversold and ready for tactical longs: $MASI $ICUI $LLY $HAE 👍
0 · Reply
healthcareguru
healthcareguru Aug. 8 at 5:34 PM
All of these are massively and unjustifiably oversold despite strong or decent fundamentals…BUY THE F*CKING DIP on all of these: $LLY $HAE $EVH $ICUI $MASI 💪👍
1 · Reply
Latest News on MASI
Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:03 PM EDT - 16 days ago

Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript


Masimo Reports Second Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 17 days ago

Masimo Reports Second Quarter 2025 Results


Masimo to Present in the Jefferies Global Healthcare Conference

May 27, 2025, 9:00 AM EDT - 3 months ago

Masimo to Present in the Jefferies Global Healthcare Conference


Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript

May 6, 2025, 10:15 PM EDT - 3 months ago

Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript


Masimo Reports First Quarter 2025 Results

May 6, 2025, 4:10 PM EDT - 3 months ago

Masimo Reports First Quarter 2025 Results


Masimo to Sell Consumer Audio Business to HARMAN International

May 6, 2025, 4:10 PM EDT - 3 months ago

Masimo to Sell Consumer Audio Business to HARMAN International


Masimo to Sell Audio Business to Harman After Investor Outrage

May 6, 2025, 4:00 PM EDT - 3 months ago

Masimo to Sell Audio Business to Harman After Investor Outrage


Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 6:02 PM EST - 6 months ago

Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript


Masimo Taps Katie Szyman as Permanent CEO

Jan 21, 2025, 5:22 PM EST - 7 months ago

Masimo Taps Katie Szyman as Permanent CEO


Masimo names Becton Dickinson's Katie Szyman CEO

Jan 21, 2025, 4:56 PM EST - 7 months ago

Masimo names Becton Dickinson's Katie Szyman CEO


Masimo Announces Leadership Transition

Jan 21, 2025, 4:00 PM EST - 7 months ago

Masimo Announces Leadership Transition


Masimo to Present in the Jefferies London Healthcare Conference

Nov 14, 2024, 9:00 AM EST - 10 months ago

Masimo to Present in the Jefferies London Healthcare Conference


Masimo to Present in Stifel 2024 Healthcare Conference

Nov 13, 2024, 9:00 AM EST - 10 months ago

Masimo to Present in Stifel 2024 Healthcare Conference


Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:57 PM EST - 10 months ago

Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript


Masimo Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:05 PM EST - 10 months ago

Masimo Reports Third Quarter 2024 Financial Results


Masimo Terminates Founder Kiani as CEO

Oct 29, 2024, 5:57 PM EDT - 10 months ago

Masimo Terminates Founder Kiani as CEO


Apple wins $250 from Masimo in watch patent trial

Oct 26, 2024, 3:53 PM EDT - 10 months ago

Apple wins $250 from Masimo in watch patent trial

AAPL


Masimo smartwatches infringe Apple design patents, US jury says

Oct 25, 2024, 6:16 PM EDT - 10 months ago

Masimo smartwatches infringe Apple design patents, US jury says

AAPL


Masimo's Joe Kiani resigns as CEO after board ouster

Sep 25, 2024, 9:17 AM EDT - 11 months ago

Masimo's Joe Kiani resigns as CEO after board ouster


Masimo Provides Leadership and Business Updates

Sep 25, 2024, 9:00 AM EDT - 11 months ago

Masimo Provides Leadership and Business Updates


Politan Comments on Results of Masimo's 2024 Annual Meeting

Sep 19, 2024, 5:39 PM EDT - 1 year ago

Politan Comments on Results of Masimo's 2024 Annual Meeting


Masimo CEO on Partnership With Google and Qualcomm

Sep 16, 2024, 4:02 PM EDT - 1 year ago

Masimo CEO on Partnership With Google and Qualcomm

GOOG GOOGL QCOM


DonCorleone77
DonCorleone77 Aug. 21 at 10:17 AM
$MASI $AAPL From Bloomberg Law: "Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool" https://news.bloomberglaw.com/daily-labor-report/masimo-sues-us-customs-over-apple-restoring-watchs-oxygen-tool
0 · Reply
smartkarma
smartkarma Aug. 21 at 6:06 AM
$MASI | Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market? "Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/masimo-corporation-unveils-next-gen-root-monitor-can-its-innovations-help-grap-a-larger-pie-of-the-market
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 21 at 3:01 AM
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature $MASI $AAPL https://stocktwits.com/news/equity/markets/apple-s-watch-war-heats-up-masimo-takes-customs-to-court-over-blood-oxygen-feature/chsSKuFRdL7
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:13 PM
$MASI shares lost 4.6% following FDA clearance for expanded O3 Regional Oximetry indications — a buying opportunity? 🤔 FDA nod for expanded O3 Regional Oximetry indications could drive growth in high-margin brain monitoring, yet shares are down 11.2% year-to-date, underperforming the industry’s 7.6% decline. Discover what's next for Masimo 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-body-8701&ADID=SYND_STOCKTWITS_TWEET_2_2740478_BODY_8701
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 5:13 PM
$MASI dips on FDA win? 🤔 The company just got clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups — yet shares are trading lower. See the full bull/bear setup here 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-teaser-8700&ADID=SYND_STOCKTWITS_TWEET_2_2740478_TEASER_8700
0 · Reply
11thestate
11thestate Aug. 18 at 8:51 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08182025_1 #MASI
0 · Reply
lipmaz
lipmaz Aug. 17 at 12:05 AM
$MASI or $IRTC you can only choose one?
0 · Reply
theflynews
theflynews Aug. 14 at 3:19 PM
Video: Why Masimo Is Sliding Today - $MASI - https://thefly.com/permalinks/entry.php/MASIid4183702?1755184131C38
0 · Reply
healthcareguru
healthcareguru Aug. 11 at 1:54 PM
Dramatically oversold and ready for tactical longs: $MASI $ICUI $LLY $HAE 👍
0 · Reply
healthcareguru
healthcareguru Aug. 8 at 5:34 PM
All of these are massively and unjustifiably oversold despite strong or decent fundamentals…BUY THE F*CKING DIP on all of these: $LLY $HAE $EVH $ICUI $MASI 💪👍
1 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:09 PM
$MASI posts strong Q2 earnings beat — despite shares dipping 2.7% after hours. 🤔 📈 Adjusted EPS surged 46.2% YoY, beating the Zacks Consensus Estimate by 8.1% 💰 Revenue grew 7.9% YoY on a reported basis, driven by consumable sales, despite lower capital sales See the full breakdown here 👉 https://www.zacks.com/stock/news/2674068/masi-stock-slips-despite-q2-earnings-and-revenue-beat-margins-expand?cid=sm-stocktwits-2-2674068-body-6468&ADID=SYND_STOCKTWITS_TWEET_2_2674068_BODY_6468
0 · Reply
garygb
garygb Aug. 6 at 5:51 PM
$MASI Sold off for no reason. I'm buying in
0 · Reply
healthcareguru
healthcareguru Aug. 6 at 5:13 PM
$MASI no reason for this to be down so much on a nice EPS guide boost; bouncing nicely…looks like it wants a >$150 close. 👍
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 4:56 PM
$MASI crushed Q2 — so why is the stock slipping? 🤔 Earnings and revenue both topped estimates, margins expanded, and the 2025 outlook was raised. Full breakdown here 👉 https://www.zacks.com/stock/news/2674068/masi-stock-slips-despite-q2-earnings-and-revenue-beat-margins-expand?cid=sm-stocktwits-2-2674068-teaser-6406&ADID=SYND_STOCKTWITS_TWEET_2_2674068_TEASER_6406
0 · Reply
JarvisFlow
JarvisFlow Aug. 6 at 4:06 PM
Piper Sandler updates rating for Masimo ( $MASI ) to Overweight, target set at 200 → 210.
0 · Reply
nanidog
nanidog Aug. 6 at 2:51 PM
$MASI earning out
0 · Reply
1986iamwallstreet
1986iamwallstreet Aug. 5 at 8:46 PM
$MASI bleeding 🩸
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Aug. 4 at 12:15 AM
$MASI sitting at $154 while $EW trading at $79. MASI showing -23% volume vs avg, EW down -38%. Both MedicalTech plays, but MASI's price action and volume holding stronger. Is the sector showing signs of consolidation?
0 · Reply
scientificway
scientificway Aug. 3 at 4:26 AM
$MASI, Check it out, huge up beat of rev.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 30 at 8:38 PM
$MASI Great piece that accurately captures MASI's current position. So if you want to refresh your understanding of MASI or learn about MASI for the first time, this is essential reading. https://beyondspx.com/article/masimo-refocused-healthcare-engine-delivers-strong-growth-and-margin-expansion-masi
0 · Reply
11thestate
11thestate Jul. 25 at 5:19 AM
$MASI reached a settlement with investors to resolve claims that it misled the market about its ability to sustain growth following its $1 billion acquisition of Sound United. Who’s eligible? Anyone who bought and held $MASI stock between May 4, 2022, and August 8, 2023. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is not yet determined as the settlement terms are still being finalized. Can I still file? Yes — late claims are being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/masimo-investor-lawsuit
0 · Reply
11thestate
11thestate Jul. 16 at 12:26 PM
$MASI reached a settlement with investors to resolve claims that it misled the market about its ability to sustain growth following its $1 billion acquisition of Sound United. Who’s eligible? Anyone who bought and held $MASI stock between May 4, 2022, and August 8, 2023. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is not yet determined as the settlement terms are still being finalized. Can I still file? Yes — late claims are currently being considered, pending court approval. When do payouts happen? The payout timeline will be announced after the court finalizes the settlement terms. To file your claim: https://11th.com/cases/masimo-investor-lawsuit
0 · Reply